TScan Therapeutics Inc.

NASDAQ: TCRX · Real-Time Price · USD
1.80
-0.01 (-0.55%)
At close: Aug 15, 2025, 3:59 PM
1.77
-1.94%
After-hours: Aug 15, 2025, 05:29 PM EDT

TScan Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-2.67 -4.29 -0.57 -2.21
PEG Ratio
0.17 0.09 -0.02 -0.02
PS Ratio
120.90 18.17 2.75 10.61
PB Ratio
1.41 2.53 0.37 0.67
P/FCF Ratio
-2.97 -5.93 -0.53 -1.84
P/OCF Ratio
-3.07 -6.23 -0.56 -2.21
OCF/S Ratio
-39.35 -2.92 -4.91 -4.8
Debt / Equity Ratio
0.40 0.61 0.86 0.04
Quick Ratio
8.14 6.51 6.94 7.76
Current Ratio
8.14 6.51 6.94 7.76
Asset Turnover
0.01 0.08 0.07 0.05
Interest Coverage
-36.91 -24.86 -56.66 n/a
Return on Equity
-0.53 -0.59 -0.66 -0.3
Return on Assets
-0.34 -0.33 -0.33 -0.26
Return on Invested Capital
-0.39 -0.38 -0.35 -0.29
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
1.00 -3.19 0.62 0.67
Net Profit Margin
-45.28 -4.24 -4.86 -4.79
Pretax Profit Margin
-45.28 -4.24 -4.89 -4.79
Operating Profit Margin
-47.88 -4.44 -4.92 -4.8
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-42.52 -3.81 -4.43 -4.47